Skip to main content

Day: September 8, 2022

Ducommun to Participate in RBC Global Industrials Conference

SANTA ANA, Calif., Sept. 08, 2022 (GLOBE NEWSWIRE) — Ducommun Incorporated (NYSE: DCO) (“Ducommun” or the “Company”) announced today that Stephen G. Oswald, the Company’s chairman, president and chief executive officer, and Christopher D. Wampler, vice president, chief financial officer, controller and treasurer, will participate in the upcoming RBC Capital Markets Global Industrials Conference on September 14th, 2022.   Institutional investors are welcome to contact RBC Capital Markets to arrange one-on-one meetings with management. About Ducommun Incorporated Ducommun Incorporated delivers value-added innovative products and manufacturing solutions to customers in the aerospace, defense and industrial markets. Founded in 1849, the Company specializes in two core areas – Electronic Systems and Structural Systems –...

Continue reading

H-CYTE Completes Acquisition of Jantibody

Milestone Achieved as Immunotherapeutic Agent Under Investigation for the Treatment of Ovarian Cancer Added to Asset Portfolio TAMPA, Fla., Sept. 08, 2022 (GLOBE NEWSWIRE) — H-CYTE, Inc. (OTCQB: HCYT), a medical biosciences company, announced today that the Company completed the acquisition of Jantibody. Highlights:Jantibody allows H-CYTE to diversify its asset portfolio Focus indication for ovarian cancer with the potential to be used for other diseases such as mesothelioma and pancreatic cancer H-CYTE plans to submit the Pre-IND submission for Jantibody in the second half of 2022 Plan to file for Orphan Drug Designation for Jantibody along with IND submission, which would grant the benefit of 7-year market exclusivity Equity proceeds funded the acquisition of Jantibody“Closing the Jantibody transaction marks a pivotal milestone...

Continue reading

MasterCraft Boat Holdings, Inc. Sells NauticStar Business to Iconic Marine Group

VONORE, Tenn., Sept. 08, 2022 (GLOBE NEWSWIRE) — MasterCraft Boat Holdings, Inc. (NASDAQ: MCFT) (the “Company”) today announced that its NauticStar business was acquired by a subsidiary of Iconic Marine Group. Iconic Marine Group assumed substantially all liabilities related to the NauticStar business and intends to continue operating the NauticStar business as usual. The transaction, which closed on September 2, 2022, is subject to a customary working capital adjustment. Fred Brightbill, Chief Executive Officer and Chairman of MasterCraft Boat Holdings, commented, “The sale of the NauticStar business to Iconic Marine Group will better position MasterCraft to drive profitable growth. I am confident that focusing on our MasterCraft, Crest and Aviara brands will drive enhanced value for MasterCraft shareholders, and that NauticStar...

Continue reading

The Lovesac Company Reports Second Quarter Fiscal 2023 Financial Results

Net Sales Growth of 45.0% Comparable Sales Growth of 31.1% STAMFORD, Conn., Sept. 08, 2022 (GLOBE NEWSWIRE) — The Lovesac Company (Nasdaq: LOVE) (“Lovesac” or the “Company”), the home furnishing brand best known for its Sactionals, The World’s Most Adaptable Couch™, today announced financial results for the second quarter of fiscal 2023, which ended July 31, 2022. Shawn Nelson, Chief Executive Officer, stated, “We are pleased with our second quarter results with top and bottom line performance that exceeded expectations including total net sales growth of 45% and Adjusted EBITDA of $14.1 million. We delivered these results against an industry backdrop that proved challenging for many, illustrating our market share gains off of a very small base in a large and fragmented total addressable couch + home audio market of $46.2...

Continue reading

REPEAT – TAAT® to be Sold in All 34 Texas Buc-ee’s Stores by Monday September 12

The Company confirms TAAT® Original, Smooth, and Menthol will be sold in all 34 Texas Buc-ee’s locations by Monday, September 12, 2022. Buc-ee’s will be the Company’s “Anchor Account” in TexasPhoto 1 TAAT® is already stocked in the tobacco product displays of several Buc-ee’s locations in the state of Texas, including the “world’s largest convenience store” in New Braunfels, TX (pictured above). By Monday, September 12, 2022, all 34 Texas Buc-ee’s locations will be carrying TAAT® products.LAS VEGAS and VANCOUVER, British Columbia, Sept. 08, 2022 (GLOBE NEWSWIRE) — TAAT® GLOBAL ALTERNATIVES INC. (CSE: TAAT) (OTCQX: TOBAF) (FRANKFURT: 2TP) (the “Company” or “TAAT®”) is pleased to announce that its flagship product TAAT® will be sold in all 34 Buc-ee’s locations in the state of Texas by Monday, September 12, 2022, as part of the...

Continue reading

Sernova to Present at H.C. Wainwright Annual Global Investment Conference and LifeSci Partners HealthTech Symposium

LONDON, Ontario, Sept. 08, 2022 (GLOBE NEWSWIRE) — Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage company and leader in regenerative medicine cell therapeutics, today announced it will be presenting at the upcoming H.C. Wainwright 24th Annual Global Investment Conference being held in New York, NY from September 12-14, 2022, as well as the LifeSci Partners HealthTech Symposium being held September 20-21, 2022. Company management will also be engaging in 1×1 meetings at the H.C. Wainwright conference.H.C. Wainwright 24th Annual Global Investment Conference – September 12-14, 2022Date: Tuesday, September 13, 2022Time: 9:00 – 9:30 AM ETLocation: Lotte New York PalacePresenter: Dr. Philip Toleikis, President & CEO, Sernova CorpWebcast: https://journey.ct.events/view/0510fdaf-5167-4406-a0fe-d487089da046Conference...

Continue reading

GT Biopharma to Participate in the H.C. Wainwright 24th Annual Global Investment Conference in September

BRISBANE, Calif., Sept. 08, 2022 (GLOBE NEWSWIRE) — GT Biopharma, Inc. (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company’s proprietary natural killer (NK) cell engager, TriKE® platform, today announced that management will present in-person at H.C. Wainwright’s 24th Annual Global Investment Conference taking place September 12-14, 2022 at the Lotte New York Palace. Company management will also be participating in 1×1 meetings during the event.H.C. Wainwright 24th Annual Global Investment Conference – September 12-14, 2022   Title: GT Biopharma (GTBP) Company PresentationDate: Tuesday, September 13, 2022Time: 10:30 – 11:00 am EDTLocation: Kennedy II, 4th Floor, Lotte New York PalaceWebcast Link: Register here*a replay of...

Continue reading

Parsons to Present at The Morgan Stanley 10th Annual Laguna Conference

CENTREVILLE, Va., Sept. 08, 2022 (GLOBE NEWSWIRE) — Parsons Corporation (NYSE: PSN) announced today that Carey Smith, chair, president, and chief executive officer, and Matt Ofilos, chief financial officer, will present at the 2022 Morgan Stanley 10th Annual Laguna Conference in Dana Point, California on Wednesday, September 14, 2022, at approximately 1:25 p.m. Pacific Time (4:25 p.m. Eastern Time). This presentation will be available live via webcast on the investor relations section of Parsons’ website (https://investors.parsons.com/). A replay of the webcast also will be available on the website for 30 days. About Parsons Parsons (NYSE: PSN) is a leading disruptive technology provider in the national security and critical infrastructure markets, with capabilities across cybersecurity, missile defense, space, C5ISR, transportation,...

Continue reading

Navios Maritime Holdings Inc. Reports Financial Results for the Second Quarter and Six Months Ended June 30, 2022

Net Income$45.0 million net income in Q2 2022 $40.0 million net income in H1 2022Revenue10.9% increase to $159.2 million in Q2 2022 10.1% increase to $287.0 million in H1 2022Cash from operating activities$69.7 million cash provided by operating activities in Q2 2022 $86.1 million cash provided by operating activities in H1 2022EBITDA, a non-GAAP measure22.8% increase to $98.9 million in Q2 2022 27.8% increase to $172.7 million in H1 2022Recent Developments$835.0 million sale of 36-vessel drybulk fleet completed $784.2 million reduction in liabilitiesPost sale63.8% controlling stake in NSAL 10.3% passive stake in NMMGRAND CAYMAN, Cayman Islands, Sept. 08, 2022 (GLOBE NEWSWIRE) — Navios Maritime Holdings Inc. (“Navios Holdings” or the “Company”) (NYSE: NM), a global seaborne shipping and logistics...

Continue reading

Wallbridge Commissions Updated Detour-Fenelon Gold Trend Resource Estimate and Commences Work on Preliminary Economic Assessment

TORONTO, Sept. 08, 2022 (GLOBE NEWSWIRE) — Wallbridge Mining Company Limited (TSX:WM, OTCQX:WLBMF) (“Wallbridge” or the “Company”) today announced that it has commissioned an update to the 2021 mineral resource estimate for its flagship Fenelon Gold (“Fenelon”) and Martiniere (“Martiniere”) project (the “2023 MRE”). In addition, the Company has initiated a preliminary economic assessment (“PEA”) of Fenelon. For Fenelon, the 2023 MRE will incorporate data from an additional 100,000 metres of drilling completed since the 2021 MRE, and will focus on optimizing the resource for a predominantly underground bulk mining operation, as opposed to the less selective large open pit approach used in 2021. The 2023 MRE will also include an updated resource for Martiniere, situated 30 km west of Fenelon, where the Company has completed an additional...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.